Frédéric Bibeau

16.4k total citations · 4 hit papers
193 papers, 10.7k citations indexed

About

Frédéric Bibeau is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Frédéric Bibeau has authored 193 papers receiving a total of 10.7k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Oncology, 54 papers in Pathology and Forensic Medicine and 52 papers in Surgery. Recurrent topics in Frédéric Bibeau's work include Colorectal Cancer Treatments and Studies (66 papers), Genetic factors in colorectal cancer (42 papers) and Colorectal Cancer Surgical Treatments (27 papers). Frédéric Bibeau is often cited by papers focused on Colorectal Cancer Treatments and Studies (66 papers), Genetic factors in colorectal cancer (42 papers) and Colorectal Cancer Surgical Treatments (27 papers). Frédéric Bibeau collaborates with scholars based in France, Switzerland and United Kingdom. Frédéric Bibeau's co-authors include Marc Ychou, Florence Boissière‐Michot, Philippe Rouanet, Astrid Lièvre, Evelyne Lopez‐Crapez, Charles Theillet, Thierry André, Michel Ducreux, Pierre Laurent‐Puig and Caroline Mollévi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Frédéric Bibeau

184 papers receiving 10.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab

2008 1.1k citations Astrid Lièvre, Jean‐Baptiste Bachet et al. Journal of Clinical Oncology profile →
ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach

2019 685 citations Frédéric Bibeau et al. Annals of Oncology profile →
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA

2014 530 citations Alain R. Thierry, Florent Moulière et al. profile →
Analysis of PTEN , BRAF , and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer

2009 529 citations Pierre Laurent‐Puig, Anne Cayre et al. Journal of Clinical Oncology profile →

Peers

Frédéric Bibeau

ONCOL

PFM

PRM

Gabriella Fontanini Italy

Robert Radinsky United States

Robert L. Camp United States

Vincent T.H.B.M. Smit Netherlands

Filip Jankú United States

Inti Zlobec Switzerland

Alessandro Lugli Switzerland

Lynette M. Sholl United States

Joan Albanell Spain

Timothy J. Yeatman United States

Gabriella Fontanini Italy

Frédéric Bibeau

7.2k ×1.1

ONCOL

5.3k ×1.6

2.7k ×0.9

1.6k ×0.7

PFM

4.7k ×1.9

PRM

Citations per year, relative to Frédéric Bibeau Frédéric Bibeau (= 1×) peers Gabriella Fontanini

Countries citing papers authored by Frédéric Bibeau

Since Specialization

Citations

This map shows the geographic impact of Frédéric Bibeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Bibeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Bibeau more than expected).

Fields of papers citing papers by Frédéric Bibeau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Bibeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Bibeau. The network helps show where Frédéric Bibeau may publish in the future.

Co-authorship network of co-authors of Frédéric Bibeau

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Bibeau. A scholar is included among the top collaborators of Frédéric Bibeau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Bibeau. Frédéric Bibeau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dartigues, Peggy, Vahan Képénékian, Véronique Verrièle, et al.. (2025). Insights into the Clinical Prognosis of High-grade Appendiceal Mucinous Neoplasms. The American Journal of Surgical Pathology. 49(5). 499–507.

Truntzer, Caroline, David Rageot, Françoise Beltjens, et al.. (2024). Deep Multiple Instance Learning Model to Predict Outcome of Pancreatic Cancer Following Surgery. Biomedicines. 12(12). 2754–2754. 1 indexed citations

González‐Moreno, Santiago, Marcello Deraco, Shigeki Kusamura, et al.. (2024). Education and Training in Peritoneal Surface Oncology. Journal of Surgical Oncology. 130(6). 1249–1256. 1 indexed citations

Ramanah, R., et al.. (2024). Prevalence and significance of HPV DNA detection below the clinical threshold of the commercial kit Alinity m HR‐HPV assay (Abbott). Journal of Medical Virology. 96(2). e29465–e29465.

Monnien, Franck, Sophie Félix, Zohair Selmani, et al.. (2024). Temporal and spatial heterogeneity of HER2 status in metastatic colorectal cancer. Diagnostic Pathology. 19(1). 88–88. 3 indexed citations

Baba, Ranim El, Sébastien Pasquereau, Sandy Haidar Ahmad, et al.. (2023). EZH2-Myc driven glioblastoma elicited by cytomegalovirus infection of human astrocytes. Oncogene. 42(24). 2031–2045. 26 indexed citations

Malka, David, Astrid Lièvre, Thierry André, et al.. (2020). Immune scores in colorectal cancer: Where are we?. European Journal of Cancer. 140. 105–118. 66 indexed citations

Bonnefoi, Hervé, Gaëtan MacGrogan, Coralie Poncet, et al.. (2019). Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes. British Journal of Cancer. 120(9). 913–921. 13 indexed citations

Messaoudi, Safia El, Florent Moulière, Stanislas du Manoir, et al.. (2016). Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care. Clinical Cancer Research. 22(12). 3067–3077. 129 indexed citations

10.

Solaß, Wiebke, Christine Sempoux, Sönke Detlefsen, Norman J. Carr, & Frédéric Bibeau. (2016). Peritoneal sampling and histological assessment of therapeutic response in peritoneal metastasis: proposal of the Peritoneal Regression Grading Score (PRGS). PubMed. 1(2). 99–107. 114 indexed citations

11.

Jacot, William, Stéphane Pouderoux, Frédéric Bibeau, et al.. (2011). Variation d’expression des récepteurs hormonaux et d’HER-2 dans l’évolution du cancer du sein : quelles implications en pratique clinique ?. Bulletin du Cancer. 98(9). 1059–1070. 1 indexed citations

12.

Paillas, Salomé, Florence Boissière‐Michot, Frédéric Bibeau, et al.. (2010). Targeting the p38 MAPK Pathway Inhibits Irinotecan Resistance in Colon Adenocarcinoma. Cancer Research. 71(3). 1041–1049. 76 indexed citations

13.

Laurent‐Puig, Pierre, Anne Cayre, Gilles Manceau, et al.. (2009). Analysis of PTEN , BRAF , and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer. Journal of Clinical Oncology. 27(35). 5924–5930. 529 indexed citations breakdown →

14.

Samalin, Emmanuelle, Françoise Desseigne, Simon Thézenas, et al.. (2009). 転移性結腸直腸癌(MCRC)患者の第一線治療としてのFOLFIRINOXと併用したセツキシマブを評価する多施設第二相試験の最終結果. Annals of Oncology. 20. 20. 2 indexed citations

15.

Chanrion, Maïa, Vincent Nègre, Hélène Fontaine, et al.. (2008). A Gene Expression Signature that Can Predict the Recurrence of Tamoxifen-Treated Primary Breast Cancer. Clinical Cancer Research. 14(6). 1744–1752. 139 indexed citations

16.

Lièvre, Astrid, Jean‐Baptiste Bachet, Valérie Boige, et al.. (2008). KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab. Journal of Clinical Oncology. 26(3). 374–379. 1141 indexed citations breakdown →

17.

Tubiana-Hulin, M., Véronique Becette, Ivan Bièche, et al.. (2007). Exemestane as neoadjuvant hormonotherapy for locally advanced breast cancer: results of a phase II trial.. PubMed. 27(4C). 2689–96. 17 indexed citations

18.

Lièvre, Astrid, Jean‐Baptiste Bachet, Marc Ychou, et al.. (2007). KRAS mutations in colorectal cancer is a predictive factor of response and progression free survival in patients treated with Cetuximab.. Cancer Research. 67. 5671–5671. 7 indexed citations

19.

Côme, Christophé, Fabrice Magnino, Frédéric Bibeau, et al.. (2006). Snail and Slug Play Distinct Roles during Breast Carcinoma Progression. Clinical Cancer Research. 12(18). 5395–5402. 215 indexed citations

20.

Penault‐Llorca, Frédérique, Frédéric Bibeau, Laurent Arnould, et al.. (2005). Expression du récepteur du facteur de croissance épidermique dans les carcinomes colorectaux et rôle dans la cancérogenèse colique. Bulletin du Cancer. 92(2). 5–11. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact